OverviewChartNewsTraderScreen

BNP Paribas Aktienanleihe SNW 27..../  DE000PC1XVR8  /

EUWAX
5/10/2024  1:09:13 PM Chg.+0.92 Bid10:00:00 PM Ask10:00:00 PM Underlying Strike price Expiration date Option type
99.58EUR +0.93% -
Bid Size: -		 -
Ask Size: -		 SANOFI SA INHABER ... 90.00 EUR 6/27/2024 Call
TeleTrader 5/10 Novavax skyrockets 213.5% in premarket, highest in 16 months
TeleTrader 5/10 Novavax soars 39.6% in premarket after Sanofi license deal
GlobeNewswire 5/10 Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVI...
GlobeNewswire 5/9 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
TeleTrader 5/9 Europe opens mixed with BoE in focus
GlobeNewswire 5/8 IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/7 Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 5/2 Regeneron Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire 5/2 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 4/30 Press Release: Annual General Meeting of April 30, 2024
TeleTrader 4/25 Europe opens mostly down after corporate earnings
TeleTrader 4/25 Europe down in premarket as financial results pour in
TeleTrader 4/25 Sanofi books net sales of €10.5B in Q1, up 2.4%
GlobeNewswire 4/25 Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
GlobeNewswire 4/23 Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
GlobeNewswire 4/17 IGM Biosciences Announces Refocusing of Sanofi Collaboration
GlobeNewswire 4/17 Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in ...
GlobeNewswire 4/16 2024 DTA Summit Agenda is LIVE!!
GlobeNewswire 4/10 Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Upda...
GlobeNewswire 4/9 Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targe...
GlobeNewswire 3/29 Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/22 Press Release: Availability of the Q1 2024 Memorandum for modelling purposes
GlobeNewswire 3/14 MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Busi...
GlobeNewswire 3/14 SMDG Announces Appointment of Industry Leader Dr. Zsuzsanna Devecseri to the Board of Directors
GlobeNewswire 3/11 Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance ...